| 标题 |
A phase II study of combination daunorubicin, cytarabine (Ara‐c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression |
| 网址 | |
| DOI | |
| 其它 |
期刊:American Journal of Hematology 作者:Aref Al‐Kali; Raoul Tibes; Pamela Atherton; Jeanne Palmer; Hassan B. Alkhateeb; et al 出版日期:2023-01-10 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)